Table 2.
HTPR (n=374, 30%) | Controls (n=864, 70%) | P | |
---|---|---|---|
ATR, AU/min | 533.32±(381-615) | 154.14±(64-222) | 0.001 |
CRP, mg/L | 6.14±(0.4-3.4) | 3.93±(0.20-2.22) | 0.001 |
TSH, U/mL | 1.94±(0.9-2.3) | 1.58±(0.82-1.95) | 0.006 |
Fasting plasma glucose, mg/dL | 130.93±(94-151) | 121.87±(92-134) | 0.008 |
HbA1C,% | 6.86±(5.7-7.7) | 6.61±(5.7-7.1) | 0.066 |
Sodium, mEq/L | 139.08±(138-141) | 139.1±(137-141) | 0.932 |
Potassium, mEq/L | 4.43±(4.1-4.6) | 4.38±(4.0-4.7) | 0.057 |
Calcium, mg/dL | 9.32±(9.0-9.7) | 9.3±(9.0-9.7) | 0.462 |
HDL, mg/dL | 39.97±(31-45) | 38.94±(32-44) | 0.215 |
LDL, mg/dL | 109.69±(81-129) | 106.71±(77-128) | 0.254 |
VLDL, mg/dL | 34.89±(21-41) | 35.18±(23-43) | 0.832 |
Triglyceride, mg/dL | 176.7±(106-200) | 171.76±(112-205) | 0.480 |
Total cholesterol, mg/dL | 187.39±(146-218) | 177.44±(144-205) | 0.002 |
Hemoglobin, g/dL | 12.78±(11.0-14.2) | 13.29±(12.0-14.7) | 0.001 |
Platelet, 103 /μL | 266.68±(214-299) | 240.6±(187-280) | 0.001 |
Neutrophil, 103 /μL | 6.17±(4.2-7.3) | 6.2±(4.2-7.8) | 0.861 |
Lymphocyte, 103 /μL | 2.13±(1.6-2.5) | 2.54±(1.7-3.0) | 0.001 |
Monocyte, 103 /μL | 0.73±0.34 | 0.77±0.35 | 0.049 |
Eosinophil, 103 /μL | 0.23±(0.1-0.3) | 0.19±(0.10-0.25) | 0.001 |
MCV, fL | 87.26±(83.4-91.4) | 87.42±(84.7-91.0) | 0.680 |
RDW, % | 14.33±(12.5-15.0) | 14.15±(13-15) | 0.211 |
MPV, fL | 8.81±(8.1-9.4) | 8.88±(8.2-9.4) | 0.369 |
ATR - on treatment reactivity; AU - aggregation units; CRP - c-reactive protein; HDL - high density lipoprotein; HTPR - high on-treatment platelet reactivity of clopidogrel; LDL - low density lipoprotein; MCV - mean corpuscular volume; MPV - mean platelet volume; RDW - red cell distribution width; TSH - thyroid stimulating hormone; VLDL - very low density lipoprotein